Trial NCT04400838 ; ISRCTN
Publication Ramasamy MN, Lancet, 2020
Primary outcome on the report: The coprimary outcomes of the trial are to assess efficacy as measured by the number of cases of symptomatic, virologically confirmed COVID-19 and safety of the vaccine as measured by the occurrence of serious adverse events

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.